Napco (NASDAQ:NSSC) Misses Q4 Revenue Estimates, Stock Drops
  • February 3, 2025

Napco (NASDAQ:NSSC) Misses Q4 Revenue Estimates, Stock Drops

Electronic security systems manufacturer Napco Security Technologies (NASDAQ:NSSC) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 9.7% year on year to $42.93 million. Its GAAP profit of $0.28 per share was 16.7% below analysts’ consensus estimates.

Goldman Sachs flags up to 3% hit to its S&P 500 earnings forecasts from Trump's tariffs
  • February 3, 2025

Goldman Sachs flags up to 3% hit to its S&P 500 earnings forecasts from Trump's tariffs

Trump imposed hefty new tariffs of 25% over the weekend on imports from Mexico and Canada and 10% against China, saying this could cause "short-term" pain for Americans. "These announcements have come as a shock to many investors who expected tariffs would only be imposed if trade negotiations failed," the Wall Street brokerage said in a note dated Feb. 2. Goldman Sachs estimates that every 5-percentage-point increase in the tariff rate would lower the S&P 500's earnings per share by roughly 1% to 2%.

Markets unnerved by 'Tariff Man'
  • February 3, 2025

Markets unnerved by 'Tariff Man'

Investors fled from stocks and rushed to dollars in Monday trading in Europe and Asia, as they scrambled to process the consequences of President Donald Trump putting larger-than-expected tariffs on top U.S. trading partners. In three executive orders, Trump imposed 25% tariffs on Mexican and most Canadian imports and 10% on goods from China, starting on Tuesday. It's not as if investors didn't know that Trump, the self-proclaimed "tariff man", liked the idea of imposing tariffs.

S&P 500 Will Sink as Trump’s Tariffs Hit Earnings, Goldman’s Kostin Warns
  • February 2, 2025

S&P 500 Will Sink as Trump’s Tariffs Hit Earnings, Goldman’s Kostin Warns

(Bloomberg) -- There’s a risk of a 5% slump in US stocks over the coming months as the latest round of tariffs by the Trump administration crimp earnings forecasts, according to Goldman Sachs Group Inc. strategists.Most Read from BloombergNew York’s First ‘Passive House’ School Is a Model of Downtown DensityWhen French Communists Went on a Brutalist Building BoomTrump Paves the Way to Deputize Local Police on ImmigrationHow the 2025 Catholic Jubilee Is Reshaping RomeHistoric London Elevator Face

L’Oreal Sells €3 Billion of Sanofi Stock Back to Drugmaker
  • February 2, 2025

L’Oreal Sells €3 Billion of Sanofi Stock Back to Drugmaker

(Bloomberg) -- Cosmetics giant L’Oreal SA is selling a €3 billion ($3.1 billion) stake in Sanofi back to the French drugmaker, cashing in part of its holding after Sanofi’s shares outperformed the market over the past year.Most Read from BloombergNew York’s First ‘Passive House’ School Is a Model of Downtown DensityWhen French Communists Went on a Brutalist Building BoomTrump Paves the Way to Deputize Local Police on ImmigrationHow the 2025 Catholic Jubilee Is Reshaping RomeHistoric London Eleva